nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—CYP1A2—Clobetasol propionate—psoriasis	0.35	0.48	CbGbCtD
Oxtriphylline—SLC22A7—Methotrexate—psoriasis	0.196	0.268	CbGbCtD
Oxtriphylline—CYP1A2—Methoxsalen—psoriasis	0.184	0.252	CbGbCtD
Oxtriphylline—HDAC2—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.028	0.953	CbGdCrCtD
Oxtriphylline—HDAC2—Levonorgestrel—Hydrocortisone—psoriasis	0.00139	0.0472	CbGdCrCtD
Oxtriphylline—HDAC2—Direct p53 effectors—JUN—psoriasis	0.000546	0.00226	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CCL20—psoriasis	0.000537	0.00223	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—PPARG—psoriasis	0.000535	0.00222	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CCL20—psoriasis	0.000531	0.0022	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TAGAP—psoriasis	0.00053	0.0022	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by Insulin receptor—IL6—psoriasis	0.000526	0.00218	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TAGAP—psoriasis	0.000523	0.00217	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HCAR2—psoriasis	0.000507	0.0021	CbGpPWpGaD
Oxtriphylline—HDAC2—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.000506	0.0021	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—JUN—psoriasis	0.000492	0.00204	CbGpPWpGaD
Oxtriphylline—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000477	0.00198	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HCAR2—psoriasis	0.000472	0.00196	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—CXCL8—psoriasis	0.000467	0.00194	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—NFKBIA—psoriasis	0.000465	0.00193	CbGpPWpGaD
Oxtriphylline—HDAC2—Cell Cycle—TP53—psoriasis	0.000464	0.00192	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	0.00046	0.00191	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CCL20—psoriasis	0.000457	0.00189	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NOTCH—TP53—psoriasis	0.00044	0.00182	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TAGAP—psoriasis	0.00044	0.00182	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000437	0.00181	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—NFKBIA—psoriasis	0.000432	0.00179	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCL20—psoriasis	0.000415	0.00172	CbGpPWpGaD
Oxtriphylline—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.000411	0.0017	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TAGAP—psoriasis	0.000409	0.0017	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCL20—psoriasis	0.000409	0.0017	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—JUN—psoriasis	0.000409	0.00169	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—NOS2—psoriasis	0.000404	0.00168	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000397	0.00165	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—TYK2—psoriasis	0.000381	0.00158	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—JUN—psoriasis	0.00038	0.00157	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL20—psoriasis	0.000373	0.00155	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000371	0.00154	CbGpPWpGaD
Oxtriphylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—psoriasis	0.000369	0.00153	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—NOS2—psoriasis	0.000368	0.00153	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL20—psoriasis	0.000362	0.0015	CbGpPWpGaD
Oxtriphylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.000362	0.0015	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TP53—psoriasis	0.00036	0.00149	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL20—psoriasis	0.000356	0.00148	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—TYK2—psoriasis	0.000354	0.00147	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—CARM1—psoriasis	0.000345	0.00143	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000343	0.00142	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL20—psoriasis	0.000339	0.00141	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—CXCL8—psoriasis	0.000332	0.00138	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.00033	0.00137	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL20—psoriasis	0.00033	0.00137	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—TP53—psoriasis	0.000325	0.00135	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000322	0.00134	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL20—psoriasis	0.000317	0.00132	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL20—psoriasis	0.000314	0.0013	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.0003	0.00124	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—IL6—psoriasis	0.000297	0.00123	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—NFKB1—psoriasis	0.000297	0.00123	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—NOS2—psoriasis	0.000294	0.00122	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000287	0.00119	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—CXCL8—psoriasis	0.000283	0.00117	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—NFKB1—psoriasis	0.000276	0.00114	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—TP53—psoriasis	0.00027	0.00112	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—STAT3—psoriasis	0.000267	0.00111	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL20—psoriasis	0.000264	0.00109	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000257	0.00106	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000257	0.00106	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—TP53—psoriasis	0.000251	0.00104	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—STAT3—psoriasis	0.000248	0.00103	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—IL6—psoriasis	0.000247	0.00102	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL20—psoriasis	0.000245	0.00102	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—VEGFA—psoriasis	0.000234	0.000971	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—IL6—psoriasis	0.000229	0.000952	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SOCS1—psoriasis	0.000225	0.000934	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000225	0.000933	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—CXCL8—psoriasis	0.000218	0.000905	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—TYK2—psoriasis	0.000215	0.000891	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—VEGFA—psoriasis	0.000213	0.000885	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—CXCL8—psoriasis	0.000206	0.000854	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—VDR—psoriasis	0.000206	0.000854	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SOCS1—psoriasis	0.000206	0.000852	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SOCS1—psoriasis	0.000199	0.000827	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SOCS1—psoriasis	0.000196	0.000813	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—TYK2—psoriasis	0.000196	0.000813	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—TYK2—psoriasis	0.00019	0.000788	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—CXCL8—psoriasis	0.000188	0.000779	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—CXCL8—psoriasis	0.000187	0.000775	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—TYK2—psoriasis	0.000187	0.000775	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SOCS1—psoriasis	0.000187	0.000774	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—IL6—psoriasis	0.000186	0.000772	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—CXCL8—psoriasis	0.000182	0.000756	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SOCS1—psoriasis	0.000182	0.000753	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—CXCL8—psoriasis	0.000179	0.000743	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—TYK2—psoriasis	0.000178	0.000738	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TP53—psoriasis	0.000177	0.000734	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SOCS1—psoriasis	0.000175	0.000725	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—TYK2—psoriasis	0.000173	0.000718	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—IL6—psoriasis	0.000173	0.000718	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SOCS1—psoriasis	0.000173	0.000716	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—CXCL8—psoriasis	0.000171	0.000708	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—CXCL8—psoriasis	0.000171	0.000708	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—VEGFA—psoriasis	0.000171	0.000707	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—TYK2—psoriasis	0.000167	0.000691	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NDUFA5—psoriasis	0.000167	0.000691	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—LEP—psoriasis	0.000166	0.000689	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—APOE—psoriasis	0.000166	0.000689	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CXCL8—psoriasis	0.000166	0.000688	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CXCL8—psoriasis	0.000165	0.000686	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—TYK2—psoriasis	0.000165	0.000683	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HLA-A—psoriasis	0.000164	0.000679	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CXCL8—psoriasis	0.000163	0.000675	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TP53—psoriasis	0.000161	0.000668	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CXCL8—psoriasis	0.00016	0.000663	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CXCL8—psoriasis	0.000158	0.000655	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000155	0.000644	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CXCL8—psoriasis	0.000155	0.000643	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NFKBIA—psoriasis	0.000155	0.000642	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—APOE—psoriasis	0.000153	0.000634	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—LEP—psoriasis	0.000152	0.000629	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—APOE—psoriasis	0.000152	0.000629	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CXCL8—psoriasis	0.000151	0.000625	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—APOE—psoriasis	0.000147	0.00061	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—LEP—psoriasis	0.000147	0.00061	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SOCS1—psoriasis	0.000145	0.000602	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CXCL8—psoriasis	0.000145	0.000602	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—LEP—psoriasis	0.000145	0.0006	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—APOE—psoriasis	0.000145	0.0006	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—PPARG—psoriasis	0.000143	0.000595	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CXCL8—psoriasis	0.000143	0.000595	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOS2—psoriasis	0.000143	0.000591	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2S1—psoriasis	0.000142	0.000587	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NFKBIA—psoriasis	0.000141	0.000586	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—APOE—psoriasis	0.000138	0.000571	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—LEP—psoriasis	0.000138	0.000571	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NFKBIA—psoriasis	0.000137	0.000568	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SOCS1—psoriasis	0.000135	0.00056	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NFKBIA—psoriasis	0.000135	0.000559	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—APOE—psoriasis	0.000134	0.000556	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—LEP—psoriasis	0.000134	0.000556	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—LEP—psoriasis	0.000129	0.000535	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—APOE—psoriasis	0.000129	0.000535	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—psoriasis	0.000129	0.000534	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—TYK2—psoriasis	0.000129	0.000534	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NFKBIA—psoriasis	0.000128	0.000532	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—LEP—psoriasis	0.000127	0.000528	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—APOE—psoriasis	0.000127	0.000528	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TYK2—psoriasis	0.000127	0.000526	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NFKBIA—psoriasis	0.000125	0.000518	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CXCL8—psoriasis	0.000123	0.000512	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NFKBIA—psoriasis	0.00012	0.000498	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NFKBIA—psoriasis	0.000119	0.000492	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TYK2—psoriasis	0.000117	0.000484	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TYK2—psoriasis	0.000116	0.00048	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TYK2—psoriasis	0.000112	0.000466	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CXCL8—psoriasis	0.000112	0.000465	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CXCL8—psoriasis	0.00011	0.000458	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TYK2—psoriasis	0.00011	0.000458	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOE—psoriasis	0.000107	0.000444	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—LEP—psoriasis	0.000107	0.000444	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CD4—psoriasis	0.000106	0.000438	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TYK2—psoriasis	0.000105	0.000436	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—psoriasis	0.000105	0.000436	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—JUN—psoriasis	0.000103	0.000426	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TYK2—psoriasis	0.000102	0.000424	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CXCL8—psoriasis	0.000101	0.000418	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NFKBIA—psoriasis	9.98e-05	0.000414	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—psoriasis	9.96e-05	0.000413	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—LEP—psoriasis	9.96e-05	0.000413	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NFKB1—psoriasis	9.88e-05	0.00041	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TYK2—psoriasis	9.84e-05	0.000408	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CXCL8—psoriasis	9.78e-05	0.000405	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TYK2—psoriasis	9.73e-05	0.000403	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CXCL8—psoriasis	9.62e-05	0.000399	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—psoriasis	9.58e-05	0.000397	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—JUN—psoriasis	9.37e-05	0.000389	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—psoriasis	9.3e-05	0.000385	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NFKBIA—psoriasis	9.28e-05	0.000385	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CXCL8—psoriasis	9.15e-05	0.00038	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—psoriasis	9.14e-05	0.000379	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—JUN—psoriasis	9.09e-05	0.000377	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NFKB1—psoriasis	9.02e-05	0.000374	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—psoriasis	8.97e-05	0.000372	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—JUN—psoriasis	8.94e-05	0.000371	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CXCL8—psoriasis	8.9e-05	0.000369	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—STAT3—psoriasis	8.88e-05	0.000368	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NFKB1—psoriasis	8.75e-05	0.000363	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—psoriasis	8.7e-05	0.000361	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NFKB1—psoriasis	8.6e-05	0.000357	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CXCL8—psoriasis	8.57e-05	0.000355	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—JUN—psoriasis	8.51e-05	0.000353	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CXCL8—psoriasis	8.47e-05	0.000351	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—psoriasis	8.47e-05	0.000351	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—JUN—psoriasis	8.28e-05	0.000343	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NFKB1—psoriasis	8.19e-05	0.00034	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—psoriasis	8.19e-05	0.000339	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TYK2—psoriasis	8.17e-05	0.000339	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—STAT3—psoriasis	8.17e-05	0.000339	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—psoriasis	8.15e-05	0.000338	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—STAT3—psoriasis	8.11e-05	0.000336	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—psoriasis	8.05e-05	0.000334	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NFKB1—psoriasis	7.97e-05	0.00033	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—JUN—psoriasis	7.97e-05	0.00033	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—psoriasis	7.94e-05	0.000329	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—JUN—psoriasis	7.87e-05	0.000326	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—STAT3—psoriasis	7.86e-05	0.000326	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—psoriasis	7.81e-05	0.000324	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—STAT3—psoriasis	7.73e-05	0.000321	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NFKB1—psoriasis	7.67e-05	0.000318	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TYK2—psoriasis	7.6e-05	0.000315	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NFKB1—psoriasis	7.58e-05	0.000314	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—psoriasis	7.43e-05	0.000308	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.42e-05	0.000308	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—STAT3—psoriasis	7.36e-05	0.000305	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—psoriasis	7.23e-05	0.0003	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—STAT3—psoriasis	7.16e-05	0.000297	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CXCL8—psoriasis	7.12e-05	0.000295	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—psoriasis	6.96e-05	0.000289	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CARM1—psoriasis	6.92e-05	0.000287	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—STAT3—psoriasis	6.89e-05	0.000286	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—psoriasis	6.88e-05	0.000285	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—STAT3—psoriasis	6.81e-05	0.000282	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—psoriasis	6.78e-05	0.000281	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCL8—psoriasis	6.62e-05	0.000274	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—JUN—psoriasis	6.62e-05	0.000274	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.46e-05	0.000268	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NFKB1—psoriasis	6.37e-05	0.000264	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—psoriasis	6.29e-05	0.000261	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—psoriasis	6.2e-05	0.000257	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—psoriasis	6.19e-05	0.000257	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—JUN—psoriasis	6.15e-05	0.000255	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—psoriasis	6e-05	0.000249	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NFKB1—psoriasis	5.92e-05	0.000246	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—psoriasis	5.9e-05	0.000245	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—psoriasis	5.78e-05	0.00024	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—STAT3—psoriasis	5.72e-05	0.000237	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—psoriasis	5.71e-05	0.000237	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—psoriasis	5.66e-05	0.000235	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—psoriasis	5.62e-05	0.000233	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—psoriasis	5.49e-05	0.000228	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—psoriasis	5.46e-05	0.000227	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—psoriasis	5.4e-05	0.000224	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—psoriasis	5.37e-05	0.000223	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—STAT3—psoriasis	5.32e-05	0.000221	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—psoriasis	5.26e-05	0.000218	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—psoriasis	5.2e-05	0.000216	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—psoriasis	5.14e-05	0.000213	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—psoriasis	5e-05	0.000207	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—psoriasis	4.81e-05	0.0002	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—psoriasis	4.76e-05	0.000197	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—psoriasis	4.37e-05	0.000181	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CAT—psoriasis	4.25e-05	0.000176	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—psoriasis	4.06e-05	0.000168	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—psoriasis	4e-05	0.000166	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—psoriasis	3.72e-05	0.000154	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—psoriasis	3.31e-05	0.000137	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARG—psoriasis	2.88e-05	0.000119	CbGpPWpGaD
